News

Combination therapy shows superior efficacy in reducing albumin in chronic kidney disease and type 2 diabetes patients
New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...
Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
New 100-week data from the ongoing Phase I/II study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...
ascopubs.org4d
Safety and response with nivolumab (anti-PD-1; BMS-936558, ONO-4538) plus erlotinib in patients (pts) with epidermal growth factor receptor mutant (EGFR MT) advanced NSCLC.
Clinical activity and biomarkers of MEDI4736, an anti-PD-L1 antibody, in patients with NSCLC. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a ...